The state is nearing a key metric that will help in rolling back COVID-19 restrictions put in place on businesses and public gatherings in order to control the pandemic spread.

Glenn David was announced as group president while Wetteny Joseph joins the company as executive vice president and chief financial officer.

Thomas Castellano will serve as the company’s senior vice president and chief financial officer, as Wetteny Joseph leaves the company to join Zoetis Inc.

The expansion gives the orthopedic rehabilitation facility a second location in the city, and is its fourth in Hudson County.

“This approval would be a big step for the health not just of our state broadly, but for our school communities,” Gov. Phil Murphy said during a daily COVID-19 press briefing.

Yizhe Wang joins the Princeton-based biotechnology company dedicated to bringing paradigm-shifting medicines to patients.

Physician practices here and across the country deserve to have a seat – and a voice – at the table to obtain access to the latest evidence and innovations that can allow them to operate more efficiently, evaluate and improve the quality of patient care and ultimately, the health of patients and the community in New Jersey.

This is the Somerset-based biotechnology company's third acquisition at its Gosselies location.

The announcement comes as the global drugmaker heads to the FDA for emergency approval to use the vaccine on people between the ages of 12 and 15 years of age, full approval for anyone over the age of 16, and an application by this September for anyone between the ages of 2 and 11.

The goal is to work toward a definitive agreement that will create a more comprehensive and sustainable health care system for the surrounding community.

The standalone company is expected to leverage the Franklin Lakes-based medical technology organization's position as a global leader in insulin delivery, and expand its presence in the sector's large and high-growth market.

The 35,000-square-foot, state-of-the-art laboratory space is located at a site formerly occupied by Bristol Myers Squibb. Over time, the company plans to expand further within the same location.